Daniel Eros, Ph.D.
Affiliations: | 2005 | Semmelweis Egyetem, Hungary |
Area:
Molecular Biology, PharmacyGoogle:
"Daniel Eros"Parents
Sign in to add mentorGyorgy Keri | grad student | 2005 | Semmelweis Egyetem | |
(Structure-activity/property relationships of kinase inhibitors based on calculated and measured parameters, and applications in drug design and development.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zsákai L, Sipos A, Dobos J, et al. (2019) Targeted drug combination therapy design based on driver genes. Oncotarget. 10: 5255-5266 |
Artarini A, Meyer M, Shin YJ, et al. (2019) Regulation of influenza a virus mRNA splicing by CLK1. Antiviral Research |
Herczenik E, Varga Z, Eros D, et al. (2009) Protein kinase inhibitor-induced endothelial cell cytotoxicity and its prediction based on calculated molecular descriptors. Journal of Receptor and Signal Transduction Research. 29: 75-83 |
Hegymegi-Barakonyi B, Eros D, Szántai-Kis C, et al. (2009) Tyrosine kinase inhibitors - small molecular weight compounds inhibiting EGFR. Current Opinion in Molecular Therapeutics. 11: 308-21 |
Eros D, Orfi L, Csuka I, et al. (2009) Binding specificity of the L-arginine transport systems in mouse macrophages and human cells overexpressing the cationic amino acid transporter hCAT-1. Amino Acids. 36: 483-92 |
Eros D, Szántai-Kis C, Kiss R, et al. (2008) Structure -activity relationships of PDE5 inhibitors. Current Medicinal Chemistry. 15: 1570-85 |
Székely R, Wáczek F, Szabadkai I, et al. (2008) A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling. Immunology Letters. 116: 225-31 |
Szántai-Kis C, Kövesdi I, Eros D, et al. (2006) Prediction oriented QSAR modelling of EGFR inhibition. Current Medicinal Chemistry. 13: 277-87 |
Keri G, Orfi L, Eros D, et al. (2006) Signal transduction therapy with rationally designed kinase inhibitors Current Signal Transduction Therapy. 1: 67-95 |
Székelyhidi Z, Pató J, Wáczek F, et al. (2005) Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives. Bioorganic & Medicinal Chemistry Letters. 15: 3241-6 |